Magnetic Resonance Spectrobiopsy for Prediction of Isocitrate Dehydrogenase Mutation in Glioma

被引：3
|
作者：
Grasso, Giovanni [1 ]
Torregrossa, Fabio [1 ]
机构：
[1] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Sect Neurosurg, Palermo, Italy
来源：
WORLD NEUROSURGERY | 2020年 / 134卷
关键词：
2HG; 2-Hydroxyglutarate; Glioma; Magnetic resonance spectroscopy; MRS; Neuroimaging; GLIOBLASTOMA-MULTIFORME; RESECTION; EXTENT; BRAIN; 2-HYDROXYGLUTARATE; ERYTHROPOIETIN; SPECTROSCOPY; INHIBITOR; DISEASE;
D O I：
10.1016/j.wneu.2019.10.181
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：187 / 189
页数：3
相关论文
共 50 条
  • [21] Rapid detection of isocitrate dehydrogenase 1 mutation status in glioma based on Crispr-Cas12a
    Feng, Zhebin
    Kong, Dongsheng
    Jin, Wei
    He, Kunyu
    Zhao, Junyan
    Liu, Bin
    Xu, Hanyun
    Yu, Xin'guang
    Feng, Shiyu
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Accurate prediction of isocitrate dehydrogenase -mutation status of gliomas using SLOW-editing magnetic resonance spectroscopic imaging at 7 T MR
    Weng, Guodong
    Ermis, Ekin
    Maragkou, Theoni
    Krcek, Reinhardt
    Reinhardt, Philipp
    Zubak, Irena
    Schucht, Philippe
    Wiest, Roland
    Slotboom, Johannes
    Radojewski, Piotr
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [23] Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
    Valadez, J. Geraldo
    Sarangi, Anuraag
    Lundberg, Christopher J.
    Cooper, Michael K.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (83):
  • [24] Deep learning super-resolution magnetic resonance spectroscopic imaging of brain metabolism and mutant isocitrate dehydrogenase glioma
    Li, Xianqi
    Strasser, Bernhard
    Neuberger, Ulf
    Vollmuth, Philipp
    Bendszus, Martin
    Wick, Wolfgang
    Dietrich, Jorg
    Batchelor, Tracy T.
    Cahill, Daniel P.
    Andronesi, Ovidiu C.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [25] Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile
    Branzoli, Francesca
    Marjanska, Malgorzata
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (04) : 413 - 421
  • [26] Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
    Liu, Yang
    Lang, Fengchao
    Chou, Fu-Ju
    Zaghloul, Kareem A.
    Yang, Chunzhang
    BIOMEDICINES, 2020, 8 (09)
  • [27] Symptom management in isocitrate dehydrogenase mutant glioma
    Walbert, Tobias
    Avila, Edward K.
    Boele, Florien W.
    Hertler, Caroline
    Lu-Emerson, Christine
    van der Meer, Pim B.
    Peters, Katherine B.
    Rooney, Alasdair G.
    Templer, Jessica W.
    Koekkoek, Johan A. F.
    NEURO-ONCOLOGY PRACTICE, 2024, : i38 - i48
  • [28] Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review
    de Quintana-Schmidt, Cristian
    Jesus Alvarez-Holzapfel, Maria
    Nomdedeu-Guinot, Josep
    Bague-Rosell, Silvia
    Gallego-Rubio, Oscar
    Leidinger, Andreas
    Salgado-Lopez, Laura
    Molet-Teixido, Joan
    NEUROCIRUGIA, 2015, 26 (06): : 276 - 283
  • [29] Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells
    Wang, Ju-Bo
    Dong, Dan-Feng
    Gao, Ke
    Wang, Mao-De
    ONCOLOGY LETTERS, 2014, 7 (03) : 651 - 657
  • [30] Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis
    Low, Soon Khai
    Anjum, Zauraiz
    Mahmoud, Amir
    Joshi, Utsav
    Kouides, Peter
    THROMBOSIS RESEARCH, 2022, 219 : 14 - 21
12345